Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients

BACKGROUND: Tolvaptan, an antagonist of the vasopressin V2 receptor is a novel oral diuretic that promotes water excretion selectively. We have used furosemide as a primary diuretic and added human atrial natriuretic peptide (hANP) if necessary for fluid management postoperatively in living-donor li...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Transplant
Auteurs principaux: Imai, Shunichi, Shinoda, Masahiro, Obara, Hideaki, Kitago, Minoru, Hibi, Taizo, Abe, Yuta, Yagi, Hiroshi, Matsubara, Kentaro, Higashi, Hisanobu, Itano, Osamu, Kitagawa, Yuko
Format: Artigo
Langue:Inglês
Publié: International Scientific Literature, Inc. 2018
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248066/
https://ncbi.nlm.nih.gov/pubmed/29311539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.905817
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires